Latest Press Releases
09.04.2025 | PRESS
ACC25: New research explores top treatments, trials, and trends discussed by HCPs on social media
HCPs actively engaged on social media following key announcements at the ACC congress
10.03.2025 | PRESS
New platform allows pharma to tap into collective intelligence of millions of HCPs on social media in major therapy areas
HCP Voice, an all-new database developed by Creation Healthcare.
25.02.2025 | PRESS
Breast cancer oncologists use social media to engage with latest research developments, network with peers and educate public, research finds
Key ways in which oncologists are leveraging social media in their professional lives.
20.02.2025 | PRESS
Prostate cancer: HCPs discuss emerging therapies, clinical trials, imaging and AI diagnostics on social media
A study finds HCPs focusing on emerging therapies in prostate cancer discussions.
04.12.2024 | PRESS
X Marks the Spot: Healthcare professionals turn to X/Twitter for advocacy, education, and pharma engagement
Healthcare professionals turn to X/Twitter for advocacy, education, and pharma engagement.
06.11.2024 | PRESS
CREATION and G-Med announce partnership enabling comparative analysis of online HCP conversations
Creation Healthcare and online global physician community, G-Med, announce collaboration.
14.10.2024 | PRESS
CHEST Annual Meeting 2024: How HCPs engaged on social media
How HCPs engaged on social media during the CHEST Annual Meeting 2024.
10.09.2024 | PRESS
HCP insights consultancy launches new platform for pharmaceutical industry to identify HCP sentiment and top digital opinion leaders in key disease spaces
Users will be able to identify the most influential HCPs on social media, ranked using...
23.07.2024 | PRESS
Price Caps, Emerging Treatments, and Influential Voices: HCPs’ online COPD conversations revealed
New analysis uncovers the key topics in US HCPs’ online COPD conversations...
Bluesky offers an opportunity pharma should not ignore
A year on from its public launch last February, the self-described “social media as it should be” platform, Bluesky, has drawn in over 30 million unique users – including 16 million since the US election last November. Often seen as the alternative to X, many of those users planting roots on the platform are no doubt seeking a less chaotic space for more meaningful – and cordial – engagement.
As with all platforms, Bluesky is beginning to form its own distinct communities and hubs of conversation. One of the most promising of these is in healthcare. nd receptive environment.
Written by Daniel Ghinn
New platform allows pharma to tap into collective intelligence of millions of HCPs on social media in major therapy areas
A leading digital insights consultancy has unveiled a new platform that offers pharmaceutical companies a window into the real-time online conversations of healthcare professionals worldwide across any and all disease areas.
HCP Voice, an all-new database developed by Creation Healthcare, distils the social media conversations of millions of online HCPs in individual therapy areas, allowing users to assess – in real time – how HCPs are discussing major new treatments, clinical trials, evolving practices, individual pharmaceutical companies, and global congresses.
Social status: How pharma and health care marketing works on social media
Social media in pharma and health care marketing has gone from experimenting in channels to important communication and advertising platform.
To find out how pharma is embracing social media and for what purposes in advertising and marketing, I talked to industry experts about the different channels used today to reach consumers and physicians. Creation Healthcare did an exclusive study for Marketing & Pharma, looking at the key ways healthcare professionals specifically are using the leading social media platforms TikTok, LinkedIn X, and Instagram, and its insights are highlighted in “The HCP take” below.
Leading digital insights consultancy, Creation Healthcare, and largest online global physician community, G-Med, announce historic partnership enabling comparative analysis of online conversations of millions of HCPs worldwide
A new collaboration has been announced between leading social media insights consultancy Creation Healthcare and G-Med, the largest online global platform exclusively for physicians. The partnership has been launched to investigate the diverse ways in which healthcare professionals across the globe are using social media to interact with peers and the wider public.
Their first collaborative research project identifies where key similarities and differences lie in the nature and methods of online HCP discussion relating to breast cancer.
Clinicians discuss important sessions, colleague interactions on X during CHEST 2024
During the 2024 CHEST Annual Meeting, posts on X, formerly Twitter, from health care professionals discussed the opening session, keynote address and colleague interactions, according to a tracker from Creation Healthcare.
“The CHEST Annual Meeting was once again an example of the prominent role that social media plays in facilitating discussions among health care professionals relating to the most recent developments in health care,” Daniel Ghinn, CEO of Creation Healthcare, said in a press release.
Unpacking EASD 2024: Key themes, topics, and influencers
During EASD 2024, CREATION.co analysed the contents of 1,784 posts on X (formerly Twitter) and 60 LinkedIn posts generated by 350 individual HCPs. Social media activity ranged from reconnecting with colleagues and praising presentations to contributing thoughts and reflections on the most significant discussions in the diabetes disease and treatment space.
These unprompted conversations act as a tool with which to gain insight into the attitudes, perspectives, and concerns of those on the frontlines of diabetes care. Click here to read the full article
Clinicians talk COPD inhaler costs on X in first half of 2024
In the first half of 2024, several U.S. health care professionals discussed the price of inhalers for patients with COPD on X, formerly Twitter, according to a tracker from Creation Healthcare.
In an analysis spanning January 2024 to June 2024, Creation Healthcare evaluated 1,493 COPD-related posts on X, to find out major topics discussed by U.S. health care professionals (HCPs) on this platform.
Click here to read the full article.
A New Tool to Spot Influential Healthcare Professionals in Pharma
This week, Creation Healthcare launched a new platform that’s set to change how the pharmaceutical industry finds and connects with key voices in healthcare. Called DOL Finder, the platform was introduced at the European Association for the Study of Diabetes (EASD) meeting in Madrid, focusing initially on type 2 diabetes.
DOL Finder is designed to help pharma companies pinpoint and understand the most influential healthcare professionals (HCPs) active on social media. These digital opinion leaders, or DOLs, play a big role in conversations about diseases, treatments, and clinical trials online.
Click here to read the full article.
DOL Finder platform launch enables users to identify and monitor most influential digital healthcare professionals active in key disease spaces
The new database, developed by Creation Healthcare, was unveiled this week at the European Association for the Study of Diabetes (EASD) Conference in Madrid, and hopes to support pharmaceutical organisations in optimising their HCP engagement and marketing delivery.
Among the platforms features is a tool enabling users to identify ‘Digital Opinion Leaders’ – those healthcare professionals who have the largest impact in online discussions regarding particular diseases and treatments.
Click here to read the full article.
HCP insights consultancy launches new platform for pharmaceutical industry to identify HCP sentiment and top digital opinion leaders in key disease spaces
DOL Finder, an unprecedented new database developed by leading digital insights consultancy Creation Healthcare, will allow users to identify, monitor, and understand the most influential online healthcare professionals – or eHCPs – in any given disease space, aimed at enabling pharmaceutical organizations to optimize their HCP engagement and marketing delivery.
The application’s launch was announced this week at the 60th Annual Meeting of the European Association for the Study of Diabetes (EASD), currently taking place in Madrid. Its introduction was accompanied by a demonstration of the platform’s functionality in its first indication, type 2 diabetes.
Click here to read the full article.
Clinicians chat beta-blockers, dupilumab, ensifentrine for COPD on X in first half of 2024
In an analysis spanning January to June 2024, Creation Healthcare evaluated 1,493 COPD-related posts on X, to find out major topics discussed by U.S. health care professionals (HCPs) on this platform. These COPD-related posts came from a total of 750 HCPs, according to the release.
As Healio previously reported, one of the topics captured by researchers was discussion on COPD therapy types.
Another main topic that was tracked in this analysis was COPD treatments, and much of the online conversation about these treatments took place during the American Thoracic Society International Conference.
Click here to read the full article.
Clinicians discuss COPD ventilation support, medications on X in first half of 2024
In the first half of 2024, many posts on X, formerly Twitter, from U.S. health care professionals discussing COPD therapies focused on ventilation support, medications and palliative care, according to a tracker from Creation Healthcare.
In an analysis spanning January 2024 to June 2024, Creation Healthcare evaluated 1,493 COPD-related posts on X, to find out major topics discussed by U.S. health care professionals (HCPs) on this platform.
These COPD-related posts came from a total of 750 HCPs, according to the release.
One of the three main topics that researchers captured in this analysis was COPD therapy options, including ventilation support, medications, surgical interventions, palliative and end-of-life care, complementary and alternative therapies, and smoking cessation.
Click here to read the full article.
HCPs 72 hours ahead of mainstream media in breaking news of shingle vaccine’s dementia effects
Online healthcare professionals were more than 72 hours ahead of mainstream media in sharing the news of a seismic study linking Shingrix, a shingles vaccine, to the delayed onset of dementia in patients.
That is according to new investigative research by Creation Healthcare, who analysed the social media conversations of healthcare professionals discussing shingles vaccines immediately after the news broke in major media outlets on Thursday afternoon, 25th July.
Their study found that healthcare professionals were already actively discussing and sharing the findings of the study three days earlier, on July 22nd. The first to do so was American cardiologist Eric Topol, who shared to his near-seven hundred thousand followers a selection of quotes and specific data from the nature.com article that originally revealed the outcome of the study.
Click here to read the full article.
Deepening perspectives: How social media is driving our understanding of HCP sentiment
On the 31st of May, news broke that the NHS was launching its “world-first” cancer vaccine matchmaking programme. The scheme uses vaccines tailored to a patient’s tumours in the hope of permanently curing cancer. This news, of course, sounds fantastic – for patients, healthcare professionals (HCPs), and the NHS. Across industries, many hailed the news as a “landmark moment” for cancer treatment.
A snap analysis of over 100 posts on social media from 90 HCPs relating to cancer vaccinations found on the surface the same sense of optimism. But there appeared to be a catch. Posts following the news, at first glance, were overwhelmingly positive in sentiment. One Manchester-based immunologist labelled the vaccines a “complete game-changer”, citing its trial successes against certain forms of lymphoma.
Click here to read the full article.
Top cancer types, trials, and AI innovations: What HCPs discussed most at ASCO 2024
An analysis of the social media conversations of HCPs on the frontlines of oncology goes some way towards providing a remedy, though. In the healthcare industry particularly, online conversations offer a source of unprompted intelligence – an extremely valuable and virtually limitless opportunity for analysis. Through it, we are able to uncover the unfiltered perspectives, attitudes, and sentiments of the millions of HCPs at the forefront of healthcare delivery.
Both in the build up to and during ASCO 2024, we listened to the online conversations of more than 5,000 healthcare professionals. In total, this analysis exceeded 50,000 posts. The aim was to identify the topics that captured attention, the treatments on display that were viewed as the most encouraging, and the areas where HCPs saw practice-changing potential or hesitation-inducing drawbacks.
Click here to read the full article.
Lung cancer dominates ASCO social media conversation among health care professionals
Creation Healthcare, a leading digital insights consultancy, used its CREATION Pinpoint technology to track 37,000 posts by more than 3,000 HCPs between May 31 and June 4.
The analysis identified more than 4,000 individual posts that made reference to lung cancer — significantly more than any other cancer type.
A significant proportion of this HCP discussion centered on responses to results of several transformative trials presented at the conference. It also included conversation highlighting the growing importance of biomarker analysis, genomic profiling, and the benefits of telehealth and palliative care.
Click here to read the full article.
Healthcare professionals hail ‘game-changing’ cancer vaccine trial - but some wary that vaccine hesitancy could hinder uptake
Healthcare professionals across the globe have reacted “overwhelmingly positively” to news that thousands of NHS patients in England will be fast-tracked onto a world-first personalised cancer vaccine scheme.
In a snap analysis following the breaking news, leading digital insights consultancy Creation Healthcare found that online healthcare professionals heralded the vaccine as a “game changer”, although some expressed concerns that vaccine hesitancy among the public could hinder uptake.
Click here to read the full article
Pfizer and Novartis chiefs lead pharma's CEO influencers on social media, analysis finds
When it comes to pharma CEOs as social influencers, Pfizer’s Albert Bourla is a perfect 10 compared to his peers.
Novartis CEO Vas Narasimhan is a close second, though, with a 9.2 social impact rating — and his status is on the rise, according to Creation Healthcare’s new analysis of pharma CEO social influence.
The CREATION Healthcare analysis compared pharma leaders against each other based on the number of followers, frequency of posts, number of likes received, and the number of comments, both by the CEO and from readers, across social media channels. LinkedIn was by far the most popular platform for pharma CEOs.
Junior doctors’ strike: minority of public in favour as support wanes
Daniel Ghinn, chief executive of Creation Healthcare, said its research suggested that concerns about workload, conditions and patient safety appeared to be significant drivers of the decision to strike, as well as pay. This suggested any pay settlement would offer respite only “in the short to medium term”, he said.
Health care professionals optimistic as tirzepatide approved for obesity treatment
Also on Nov. 16, the FDA announced the approval of AstraZeneca’s Truqap (capivasertib with fulvestrant) for the treatment of hormone receptor-positive/HER2-negative metastatic breast cancer. After its approval, Paolo Tarantino, MD, a research fellow at the Dana-Farber Cancer Institute, sparked conversation related to a subanalysis of the CAPItello-291 trial, which was presented at the San Antonio Breast Cancer Symposium. Overall, HCPs expressed support for its approval, particularly in its capacity as another treatment option for patients with breast cancer.
The findings form part of a wider study by leading digital insights consultancy Creation Healthcare, and are based on the analysis of 2,313 English-language posts on X (formerly Twitter) by 1,633 HCPs throughout November, focusing on the approval and launch of new products.
Click here to read the full article
Paywalls threaten healthcare professional engagement on social media
Creation.co, a specialist digital insights consultancy, is able to track the conversations happening on the platform, and found that less than 2% of HCPs discussing the potential paywall expressed support of the idea.
Further, posts by HCPs showed that in the immediate aftermath of the comments, the number of registrations to a rival social media platform, BlueSky, had ‘dramatically increased’. According to Creation, the general sentiment expressed by HCPs was one of resentment towards potentially losing their network of medical professionals, built up over the years of using the platform.
When asked directly about the likely impact on HCPs with the imposition of a paywall, Jamie Doggett, associate director of insight at Creation, stated: “It’s clear from Creation’s studies of the digital behaviours of HCPs that X provides a unique tool for peer collaboration, and it’s still the biggest network of millions of HCPs tracked by Creation Pinpoint. We have, however, tracked HCPs saying that they refuse to pay for X. It does seem clear that charging for X will drive away some, if not all, HCPs from the platform.”
Read the full article here
Updated COVID-19 vaccines receive mixed support among health care professionals online
The findings form part of a wider study by leading digital insights consultancy, Creation Healthcare, and are based on an analysis of 2,379 English-language posts on X, the platform formerly called Twitter, by 1,555 HCPs throughout September 2023 surrounding the approval and launch of new products.
The analysts found that fewer HCPs discussed treatment approvals compared with the previous month, with 14% fewer product launch mentions compared with those in August.
Read the full article here
Health care professionals express support for postpartum depression, myeloma treatments
Creation Healthcare, a leading health care insights consultancy, used CREATION Pinpoint to analyze 2,896 English-language posts generated by 1,889 HCPs on X — formerly Twitter — from Aug. 1 to Aug. 30 to identify key aspects of discussions about FDA approvals and product launches.
Click here to read the full article
Could #MedThreads become the new #MedTwitter?
Last month, Meta, the tech giant behind Facebook, Instagram, and WhatsApp, announced the launch of Threads: a direct challenger to its now rebranded rival, X (Twitter).
Within five days, the platform had clocked up 100 million sign-ups. It wasn’t long before Elon Musk took to X to make his displeasure known. But the arrival of the new kid on the block holds implications far beyond Silicon Valley. With 370 million users worldwide, for many X has become an indispensable tool to share information both in their personal and professional lives.
Healthcare is no exception. From Turin to Tokyo, every day hundreds of thousands of healthcare professionals take to X to share professional insights and to seek solutions to clinical challenges. The implications of Threads and the impact it poses for this information sharing is significant.
First nonprescription oral contraceptive sees strong support among providers
Analysis of the online conversation among health care professionals on social media in July revealed significant online discussion and support for the first-ever nonprescription daily oral contraceptive, norgestrel 0.075 mg.
In addition to norgestrel 0.075 mg (Opill, Perrigo), the analysis revealed two other spikes in online conversation among health care professionals (HCPs) surrounding donislecel (Lantidra, CellTrans), the first cellular therapy to treat patients with type 1 diabetes, and lecanemab-irmb (Leqembi, Eisai), the new treatment for Alzheimer’s disease.
The findings form part of a wider study by Creation Healthcare, a leading digital insights consultancy, and are based on the analysis of 2,882 English-language posts on X (Twitter) by 2,037 HCPs throughout July surrounding the approval and launch of new products.
Lung cancer research key feature of ASCO 23 social media...
Lung cancer was a significant focus of social media conversation among healthcare professionals (HCPs) at this year’s annual American Society of Clinical Oncology (ASCO) conference, analysis has shown.
Research by digital insights consultancy, Creation Healthcare, found mentions of lung cancer featured in over 9,000 social media posts generated by 2,632 HCPs from across the globe during the period 1 May to 8 June 2023. Of the 9,000 posts, 43 per cent fell between the four days of the conference (2 to 6 June 2023) amounting to 15 per cent of the total ASCO 23 online conversation.
Click here to read the full article
'I had no time to say goodbye' Widow's anguish over husband's care as NHS marks 75th anniversary
But with record staff vacancies, huge waiting lists and months of industrial action, the celebrations could be overshadowed by the current crisis facing the health service.
Research carried out for ITV Meridian by Creation Healthcare shows that shortages of doctors and nurses are the biggest concern amongst those working in the health service.
Click here to read the full article
Healthcare professionals express doubt over shift from X (Twitter) to Threads, research suggests
Early analysis suggests that a greater proportion of healthcare professionals (HCPs) online have expressed negative sentiment toward the new Meta Threads platform compared to those who are positive.
The findings, produced by digital insights consultancy, Creation Healthcare, undermine speculation surrounding Threads’ capacity to usurp its more established rival, X (Twitter) and indicate that the transfer of HCP networks from Twitter to Threads may be limited.
Click here to read the full article
Recent Abbott Snafu Shines Spotlight on Social Media’s Role in Public Health Crisis Response
Social media should play a bigger part in public health crisis planning, according to a recent analysis from digital health consulting firm Creation Healthcare.
The analysis explored the crucial role that Twitter and other social media platforms played when the app for Abbott’s FreeStyle Libre system crashed earlier this month for iOS users the U.K.
Click here to read the full article
Movers and Shakers news roundup
Anni Neumann, a pharmaceutical digital insights consultant with over ten years’ industry experience, including almost seven years at leading digital insights consultancy Creation Healthcare, has been elected to the board of the British Healthcare Business Intelligence Association (BHBIA).
As an organisation, the BHBIA works to support those working in healthcare market research and data analytics by driving best practice in insight generation.
Click here to read more
Providers support approvals of therapies for prostate cancer, lymphoma, heart disease
Creation Healthcare — a leading health care insights consultancy — used CREATION Pinpoint to analyze 2,817 Twitter posts generated by 1,949 HCPs to identify key aspects of the discussions about FDA approvals of pharmaceutical products from June 1 through June 30.
They studied HCPs’ reactions and thoughts surrounding several product approvals to discover which new product launches they are discussing, as well as #WhatHCPsThink.
Click here to read the full article
Striking consultants ‘have less support than nurses’
Consultants taking strike action enjoy less support among their health-worker colleagues than nurses did, analysis suggests.
Thousands of consultants walking out have reduced NHS services to Christmas Day levels on Thursday and Friday this week, providing emergency cover only.
Click here to read the full article
Providers react positively to RSV vaccine news, plus Crohn's disease, heart failure drugs
Creation Healthcare analyzed 3,402 Twitter posts generated by 2,369 health care professionals (HCPs) discussing new pharmaceutical product launches and drug approvals from May 1 to May 31, 2023, with CREATION Pinpoint®. They studied HCPs’ reactions and thoughts surrounding several product approvals to discover which new product launches they are discussing, as well as #WhatHCPsThink. The data included mentions of drug approvals by the FDA, European Medicines Agency, National Institute for Health and Care Excellence and the Committee for Medicinal Products for Human Use, as well as mentions of drug approvals by HCPs in their Twitter conversations.
Click here to to read the full article
Top pharma digital insights consultant elected to BHBIA board
Anni Neumann, a pharmaceutical digital insights consultant with over ten years’ industry experience, including almost seven years at leading digital insights consultancy Creation Healthcare, has been elected to the board of the British Healthcare Business Intelligence Association (BHBIA).
How social media is helping clinicians on the front line in the treatment of rare diseases Digital
Social media is unique in its capacity to gather insight into the thoughts and opinions of large numbers of healthcare professionals (HCPs) quickly.
Indeed, new research has offered insight into the applications of social media among HCPs treating, and patients suffering from, rare diseases such as lupus, myasthenia gravis, sickle cell, and multiple sclerosis. It shows how social media offers patients a community where they can share and discuss their symptoms with others living with rare diseases, but also how it can offer those treating patients a place to share their experiences, seek advice, or discuss the efficacy of new and novel treatments.
Click here to read the full article
Prestigious UK business intelligence award scooped by leading digital insights pharma consultancy
Leading digital pharma and health insights consultancy, Creation Healthcare, has been awarded the prestigious British Healthcare Business Intelligence Association’s (BHBIA) Analyst Team of the Year award. The Creation Healthcare team were given the award at the Best of Business Intelligence Awards (BOBI) last week (12 June) in London.
The award was given to the team of analysts who “best showcased their skills in turning complex datasets into an interactive, engaging report that tells a story within the data”. Teams were given just 24 hours to develop their report after being given the brief.
AAP’s obesity guidance sparks increased ‘online debate’ among physicians
Analysts at the digital insights consultancy Creation Healthcare examined online conversations of more than 4,500 health care professionals (HCPs) from more than 100 countries from January 2022 to March 2023.
The analysis considered then-current events, such as World Obesity Day, the FDA’s Jan. 3 approval of once-weekly semaglutide (Wegovy, Novo Nordisk) for adolescents with obesity and the AAP’s updated guidance from Jan. 9, which recommended weight loss medication and to evaluate teens for bariatric surgery
Understanding the reasons behind low medical cannabis prescription rates
The analysis from Creation Healthcare offers insight into key events and factors driving the online conversation over medical cannabis prescription among healthcare professionals over the period, such as the impact of EU-UK trade restrictions disrupting the supply of medical cannabis from the Netherlands in early 2021.
Meet the women at the forefront of digital oncology
The women chosen by Creation Healthcare are established opinion leaders and women with emerging influence. They hold a range of professional roles, ranging from directors of eminent institutions to younger oncologists. Several metrics were used to evaluate DOL status, including volume of activity, the reach of and engagement with content, the strength of their healthcare professional (HCP) peer network and the level of trust and two-way collaboration with peers online.
5 women at forefront of oncology digital space
One intention is to “[recognize and celebrate] the women and girls who are championing the advancement of transformative technology and digital education.”
In line with this goal, CREATION.co celebrates five female digital opinion leaders in oncology, all of whom use digital means to educate their medical peers, and achieve social change or optimal medical practice.
2022 "Children's nurses among 100,000 who will strike next month."
2022 "Exclusive: Patient safety central in nurse strike conversations."
The analysis found more than 3,900 UK health professionals using their social media accounts to discuss potential strike action since the start of 2021. Posts on this topic have “soared” in recent months amid union ballots.
Online support for strikes among health professionals grew from 59% in September 2021 to 85% in September 2022, and many of those pressing for strikes were doing so because of fears about current “dangers to patient safety” within the health service.
These are the findings of new analysis carried out by specialist digital insights consultancy firm, Creation Healthcare, which explored conversations among health professionals on social media.
Click here to Read more
2022 "New psilocybin data spark favorable social media conversation among HCPs in US"
Medical studies from as early as the 1960s have documented psilocybin’s potentially negative effects — typically “bad trips” (ie, experiences of fear or dysphoria).
However, an increasing amount of research has explored its use to treat drug dependence, anxiety or mood disorders. In some cases, psychedelic drugs such as psilocybin have been deemed less harmful than alcohol or tobacco.
An analysis of social media posts by CREATION.co revealed health care professionals in various specialties engaging in the online conversation about psilocybin, particularly with regard to studies
2022 "Pandemic Saw Rise In Health And Climate Change Related Misinformation, Study Reveals"
‘Tackling the Infodemic’
The challenge is compounded by evidence suggesting that fake news stories relating to the climate have been increasing for a sustained period, and that the reach when each outbreak of fake news does occur is also growing.
This is supported by the study’s research into planetary health conversation online and internet users. The study shows the growth in the number of internet users globally and the number of authors and posts in online planetary health conversations. Despite seeing a reduction in the level of online conversation surrounding planetary health over the course of the pandemic, more recent figures point to a recovery and a return to the pre-pandemic trajectory.
Fears surrounding the growing ‘infodemic’ have prompted experts, such as Daniel Ghinn, Founder and CEO of Creation Healthcare whose team led on the research with GSK, to urge the healthcare industry to seize the opportunity to play a greater role in combating the spread of online misinformation
2022 "OUR HERO How Deborah James is continuing to save lives after death as interest in cancer sites surge following death"
Research produced by digital insights company Creation Healthcare also found that Debs was able to engage millions of people through her toughest moments.
Spokeswoman Mary Kangley said: “The enormous impact that Dame Deborah James has had, is clear. Ever since she was first diagnosed, her advocacy and awareness mission hasn’t just touched those suffering from cancer and their loved ones.
“It’s also resonated with the countless doctors, nurses and other healthcare professionals treating cancer day in and day out.”
2022 "Absolutely remarkable’: HCPs tweet excitement for study of dostarlimab in rectal cancer"
Calling the research “beyond impressive” and “absolutely remarkable,” HCPs took to Twitter to heap praise on study results presented at the ASCO Annual Meeting describing treatment with dostarlimab in a subset of rectal cancer patients.
2022 Healio "DYNAMIC trial data spark Twitter talk about ‘future of patient risk stratification"
The potential for ctDNA-guided management to reduce adjuvant chemotherapy by half without compromising recurrence-free survival sparked interest on social media after a presentation at the ASCO Annual Meeting.
Fresh off a presentation by Jeanne Tie, MD, MBChB, FRACP, on the DYNAMIC trial, Healio and Creation Healthcare, a digital insights company, analyzed health care provider sentiments on the results.
2022 - Health Europa "Medical misinformation: What can be done to tackle fake health news ?"
“Research has shown the inescapable influence of social media and the need for a coordinated governmental response to combat fake health news.It’s also shown that doctors and other medical professionals are pioneers and well ahead of governments and health bodies in the fight against medical misinformation, including around COVID-19.”
Click here to view the full article
2022 - From Comment Central "World Asthma Day 2022: Environmental impact of respiratory care is key issue"
Commenting on the research, CREATION.co insights data analyst Mark Sullivan said: “Our latest research offers a variety of insights surrounding World Asthma Day 2022. It demonstrates how healthcare professionals and patients themselves are becoming increasingly aware of the environmental implications of different treatment methods and, where possible, ways to mitigate any detrimental effects.”
Click here to view the full article
2022 - From News Medical Life Sciences "Research suggests Twitter as a powerful tool to drive awareness about pancreatic cancer"
Commenting on the findings, lead author of the report and Associate Director of Insight at CREATION.co, Jamie Doggett, said:
“The findings of this study are positive and significant. They indicate a high level of social media engagement in the pancreatic cancer conversation on Twitter among clinicians, patients, and the public. Healthcare professionals and advocacy groups can leverage this social media engagement to raise awareness and gain valuable feedback to create an ongoing loop.”
Click here to read the full article
2022 - From Sickle cell society "New research reveals healthcare professionals are critical of health inequities in early diagnosis and treatment of sickle cell disorder"
Commenting on the findings, Francesca Gan, Research Associate at Creation Healthcare who led the research, commented:
“Our research makes clear that HCPs within the sickle cell therapy area are widely concerned with the issue of health inequity being faced by those of African or Caribbean descent across the world…With emerging therapies and louder HCP voices speaking out, there is hope that inequity within SCD will cease, and black minorities will receive the treatment deserved in this prevalent therapy area. Creation Healthcare has and will continue to monitor these conversations for the latest in what HCPs think about health equity.”
Click here to read the full article
2021 - Nursing Times "Exclusive: Nurse pay ‘most discussed’ issue on social media by health workforce"
“The government’s decision to initially recommend a 1% pay award for nurses was the most discussed NHS policy issue among health professionals on social media over a year-long period, it has been revealed.”
Click here to read the full article
2021 - European Pharmaceutical Review "Social media is transforming our understanding of drug safety"
“Daniel Ghinn of CREATION.co discusses the growing role social media analysis is playing in helping to provide pharmaceutical companies and health regulators with real-world evidence on drug safety.”
Click here to read the full article
2021 - From TechRound "AI-Driven Social Media Analysis Reveals How Medics Changed Their Minds On COVID-19 Vaccine Mixing"
“Using CREATION Pinpoint®, the world’s only AI-powered and human verified global database of more than 3 million healthcare professionals’ social media profiles, Daniel Ghinn, Founder & CEO of CREATION.co reveals how social media and big data analysis is revolutionising our understanding of modern medicine.”
Click here to read the full article
2021 - Diabetes Times "Leading diabetes social media influencers revealed"
“New research has identified the most active social media users who participate in the UK’s online diabetes debate.
From healthcare professionals to people with the condition, new analysis has disclosed the top ten individuals who have published the most diabetes related posts.”
Click here to read the full article
2021 - From FE News "FE exam results triggered flashpoint in 2020 pandemic mental health crisis, Creation.co study shows"
“A new study reveals the 2020 FE and Secondary exam results season combined with the start of the new academic year triggered a flashpoint of concern among doctors and other healthcare professionals (HCPs) regarding mental health among young people and the prescription of antidepressants during the pandemic.”
Click here to read the full article
2021 - From Comment Central "World Mental Health Day: Pandemic Mental Health Crisis Flashpoints Revealed"
“The rise in rates of depression and the devastating toll Coronavirus and lockdown had on the nation’s mental health is well documented. The ONS estimates rates doubled from 2019 to 2020. But, for the first time, a new study by specialist digital healthcare insights and consulting firm, CREATION.co, offers us greater understanding of the drivers behind the rise in rates of mental illness.”
Click here to read the full article
2021 - From FE News "World Mental Health Day 2021 – Exam results triggered flashpoints in pandemic mental health crisis, study shows"
“A new study reveals key flashpoints of concern among doctors and other healthcare professionals (HCPs) regarding public mental health and the prescription of antidepressants during the pandemic.”
Click here to read the full article
From PharmaVoice Innovation issue 2015
“…until Creation Pinpoint, it was impossible to isolate the views of healthcare professionals, whose conversations make up less than 5% of health-related conversations in public social media, from the noise of the public voice…
…within the first six months after its launch, 20 pharmaceutical brands had signed on to use Creation Pinpoint, and by the end of 2014, 60% of the world’s largest pharmaceutical companies were using the service”.
From SCRIP Intelligence article “Who’s Afraid Of A Tweet And A Pin?”
“Creation Healthcare filters social media content and zones in on what HCPs are saying about a specific therapeutic area. Ghinn tells Scrip that Creation Healthcare is currently is working with six of the top ten pharma companies and 20 of the top 50.”
“The idea of a Key Opinion Leader (KOL) can be used both online and in social media, but the problem is that companies don’t always know who their Digital Opinion Leader (DOL) is. DOLs are the people talking online about the pharma company but sometimes there is no direct relationship between the company and the DOL. Creation’s technology helps companies to establish who their DOLs are.”
Linked article behind SCRIP account login.
2022 - Health Europa "Social media – a powerful tool for elevating pancreatic cancer awareness"
” The research was pioneered by UK-based specialist digital insights consultancy, Creation Healthcare, working in collaboration with advocacy group Let’s Win! Pancreatic Cancer and leading medical professionals. The findings form part of a collaborative study published in March 2022 in the Journal of Medical Internet Research, a specialist digital health and open science journal.”
Click here to read the full article
2022 - Healio "Beautiful, powerful moment’ and Twitter buzz after DESTINY-Breast04 data presented"
Eleanora Teplinsky, MD (@drteplinsky). June 5, 2022. Standing ovation for results of DESTINY-Breast04. This will change practice for 50% of patients with metastatic breast cancer. This is why we all went into this field. #bcsm #ASCO22.
2021 - Diabetes Times "Top EASD 2021 online conversations revealed"
“New analysis of healthcare professionals’ social media posts during this year’s European Association for the Study of Diabetes congress has unveiled the key takeaways relating both to diabetes discussion and the event itself.”
Click here to read the full article